LIFEVANTAGE CORP Form ARS: Annual report to security holders
Filings on SEC EDGAR, newest first; amendments sit with their base form. Values are as filed.
- 2026-09-18: Form ARS; Period of report 2026-06-30; Description ARS; Document ars_-_fy26_financials.pdf.
- 2025-09-19: Form ARS; Period of report 2025-06-30; Description ARS; Document fy25ars.pdf.
- 2024-09-20: Form ARS; Period of report 2024-06-30; Description ARS; Document ars-fy2410xk.pdf.
- 2023-09-22: Form ARS; Period of report 2023-06-30; Description ARS; Document lfvn_063023-arsv2.pdf.
| Filed | Form | Period of report | Description | Document |
|---|---|---|---|---|
| 2026-09-18 | ARS | 2026-06-30 | ARS | ars_-_fy26_financials.pdf |
| 2025-09-19 | ARS | 2025-06-30 | ARS | fy25ars.pdf |
| 2024-09-20 | ARS | 2024-06-30 | ARS | ars-fy2410xk.pdf |
| 2023-09-22 | ARS | 2023-06-30 | ARS | lfvn_063023-arsv2.pdf |
| 2006-10-23 | ARS | 2006-06-30 | AUTO-GENERATED PAPER DOCUMENT | 9999999997-06-042956.paper |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Adicet Bio, Inc. (ACET) | United States | $0.078B | -0.81 |
| Valion Bio, Inc. (VBIO) | United States | $0.077B | |
| MAIA Biotechnology, Inc. (MAIA) | United States | $0.077B | -2.30 |
| iBio, Inc. (IBIO) | United States | $0.077B | -2.94 |
| Verrica Pharmaceuticals Inc. (VRCA) | United States | $0.076B | -3.39 |
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |
| Gain Therapeutics, Inc. (GANX) | United States | $0.080B | -4.40 |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |